263
Participants
Start Date
October 23, 2017
Primary Completion Date
April 29, 2022
Study Completion Date
April 29, 2022
SER-109
SER-109, an oral, biologically derived, live microbiome therapeutic that comprises purified bacterial spores
(Investigator site), New York
(Investigator site), Buffalo
(Investigator site), Pittsburgh
(Investigator site), Camp Hill
(Investigator site), Harrisburg
(Investigator site), Sayre
(Investigator site), Chevy Chase
(Investigator site), Glen Burnie
(Investigator site), Annapolis
(Investigator site), Greenville
(Investigator site), Charlotte
(Investigator site), Kinston
(Investigator site), Jacksonville
(Investigator site), Decatur
(Investigator site), Marietta
(Investigator site), Morrow
(Investigator site), Atlanta
(Investigator site), Athens
(Investigator site), Port Orange
(Investigator site), Jacksonville
(Investigator site), DeLand
(Investigator site), Orlando
(Investigator site), Miami Lakes
(Investigator site), Hialeah
(Investigator site), Pembroke Pines
(Investigator site), Pembroke Pines
(Investigator site), Homestead
(Investigator site), Miami
(Investigator site), Miami
(Investigator site), Miami
(Investigator site), Miami
(Investigator site), Miami
(Investigator site), Miami
(Investigator site), Clearwater
(Investigator site), Clearwater
(Investigator site), Naples
(Investigator site), Dothan
(Investigator site), Union City
(Investigator site), Toledo
(Investigator site), Mentor
(Investigator site), Cleveland
(Investigator site), Akron
(Investigator site), Cincinnati
(Investigator site), Centerville
(Investigator site), Evansville
(Investigator site), Chesterfield
(Investigator site), Royal Oak
(Investigator site), Detroit
(Investigator site), Flint
(Investigator site), Wyoming
(Investigator site), Iowa City
(Investigator site), Milwaukee
(Investigator site), Rochester
(Investigator site), Butte
(Investigator site), Oak Lawn
(Investigator site), Chicago
(Investigator site), Springfield
(Investigator site), Chesterfield
(Investigator site), Kansas City
(Investigator site), New Orleans
(Investigator site), Garland
(Investigator site), McKinney
(Investigator site), Southlake
(Investigator site), Houston
(Investigator site), Houston
(Investigator site), Houston
(Investigator site), Houston
(Investigator site), Spring
(Investigator site), Cypress
(Investigator site), Pasadena
(Investigator site), San Antonio
(Investigator site), Idaho Falls
(Investigator site), Boise
(Investigator site), Riverton
(Investigator site), Salt Lake City
(Investigator site), Ogden
(Investigator site), Sun City West
(Investigator site), Northridge
(Investigator site), Thousand Oaks
(Investigator site), San Dimas
(Investigator site), San Diego
(Investigator site), San Bernardino
(Investigator site), Murrieta
(Investigator site), Simi Valley
(Investigator site), Mountain View
(Investigator site), Mather
(Investigator site), Sacramento
(Investigator site), Tacoma
(Investigator site), Spokane
(Investigator site), Boston
(Investigator site), Framingham
(Investigator site), North Dartmouth
(Investigator site), Weymouth
(Investigator site), Worcester
(Investigator site), Morristown
(Investigator site), Neptune City
(Investigator site), Providence
(Investigator site), Calgary
(Investigator site), Vancouver
(Investigator site), Victoria
(Investigator site), St. John's
(Investigator site), London
(Investigator site), North Bay
(Investigator site), Scarborough Village
(Investigator site), Chicoutimi
(Investigator site), Québec
(Investigator site), Sainte-Foy
Seres Therapeutics, Inc.
INDUSTRY